Nanox To Present New Clinical Data On Nanox.ARC At ECR 2025

Benzinga · Feb 25 16:48

In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and specificity of conventional radiography.
In addition, can improve cast and metal imaging, eliminate the need for CT in some cases while at the same time reducing the patient radiation exposure and radiologist reading time.
- The Nanox.ARC outperformed standard x-ray in detecting lung nodules under simulated obesity conditions in phantoms

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Recommended

U.S. stocks closed | CPI eased inflation concerns, the Nasdaq rose over 1%; Growth Tech stocks rebounded strongly, with NVIDIA u…

wallstreetcn · Mar 12, 2025 23:14
Transaction Amount TOP 20 | AI Software stocks rebound! Applovin increased by over 14% in two days; Tesla closed up ov…

Global Market Report · Mar 12, 2025 23:24
QBTS quantum computing surpasses traditional supercomputing, with a computational speed ahead by a million years! The stock…

wallstreetcn · Mar 12, 2025 23:04
The attitude is firm! The northbound capital has made significant net purchases of Hong Kong stocks exceeding 360 billion Hong…

Brokerage China · Mar 12, 2025 23:56
Adobe's Q1 performance for fiscal year 2025 exceeded expectations, but the guidance for Q2 is relatively mediocre.

Zhitong Finance · Mar 13, 2025 00:10

Write a comment

Nanox To Present New Clinical Data On Nanox.ARC At ECR 2025

Risk Disclaimer